Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2018
This is a randomized prospective study with 2 arms to evaluate the efficacy of Levofloxacin prophylaxis in Azacytidine treated patients (MDS and AML) Levofloxacin will be given 500mg/d p.o. for the first three cycles of Azacytidine in patients randomized in arm antibacterial prophylaxis. In control arm patients will not received levofloxacin. The expected duration of subject participation is one year after randomization.
Epistemonikos ID: 4c53eb91201e7e6ab96423439658fda0b273bf49
First added on: Jan 21, 2022